Advanced Medical Isotope Debt to Equity Ratio 2013-2025 | RDGL
Current and historical debt to equity ratio values for Advanced Medical Isotope (RDGL) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Advanced Medical Isotope debt/equity for the three months ending June 30, 2025 was 0.00.
| Advanced Medical Isotope Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-06-30 | $0.00B | $0.00B | 0.04 |
| 2025-03-31 | $0.00B | $0.00B | 0.04 |
| 2024-12-31 | $0.00B | $0.00B | 0.04 |
| 2024-09-30 | $0.00B | $0.00B | 0.04 |
| 2024-06-30 | $0.00B | $0.00B | 0.10 |
| 2024-03-31 | $0.00B | $0.00B | 0.06 |
| 2023-12-31 | $0.00B | $0.00B | 0.18 |
| 2023-09-30 | $0.00B | $0.00B | 0.07 |
| 2023-06-30 | $0.00B | $0.00B | 0.07 |
| 2023-03-31 | $0.00B | $0.00B | 0.04 |
| 2022-12-31 | $0.00B | $0.00B | 0.05 |
| 2022-09-30 | $0.00B | $0.00B | 0.09 |
| 2022-06-30 | $0.00B | $0.00B | 0.24 |
| 2022-03-31 | $0.00B | $0.00B | 0.07 |
| 2021-12-31 | $0.00B | $0.00B | 0.11 |
| 2021-09-30 | $0.00B | $0.00B | 0.44 |
| 2021-06-30 | $0.00B | $0.00B | 0.37 |
| 2021-03-31 | $0.00B | $0.00B | 0.38 |
| 2020-12-31 | $0.00B | $0.00B | 28.30 |
| 2020-09-30 | $0.00B | $0.00B | -1.07 |
| 2020-06-30 | $0.00B | $0.00B | -1.38 |
| 2020-03-31 | $0.00B | $0.00B | -1.01 |
| 2019-12-31 | $0.00B | $0.00B | -1.03 |
| 2019-09-30 | $0.00B | $0.00B | -1.17 |
| 2019-06-30 | $0.00B | $0.00B | -1.04 |
| 2019-03-31 | $0.00B | $0.00B | -1.06 |
| 2018-12-31 | $0.00B | $0.00B | -1.02 |
| 2018-09-30 | $0.04B | $-0.04B | -1.00 |
| 2018-06-30 | $0.01B | $-0.01B | -1.00 |
| 2018-03-31 | $0.01B | $-0.01B | -1.00 |
| 2017-12-31 | $0.00B | $0.00B | -1.00 |
| 2017-09-30 | $0.00B | $0.00B | -1.01 |
| 2017-06-30 | $0.00B | $0.00B | -1.12 |
| 2017-03-31 | $0.00B | $0.00B | -1.01 |
| 2016-12-31 | $0.00B | $0.00B | -1.01 |
| 2016-09-30 | $0.00B | $0.00B | -1.02 |
| 2016-06-30 | $0.01B | $-0.01B | -1.02 |
| 2016-03-31 | $0.01B | $-0.01B | -1.02 |
| 2015-12-31 | $0.01B | $-0.01B | -1.03 |
| 2015-09-30 | $0.01B | $-0.01B | -1.01 |
| 2015-06-30 | $0.02B | $-0.02B | -1.01 |
| 2015-03-31 | $0.02B | $-0.02B | -1.00 |
| 2014-12-31 | $0.02B | $-0.02B | -1.00 |
| 2014-09-30 | $0.01B | $-0.01B | -1.02 |
| 2014-06-30 | $0.01B | $-0.01B | -1.03 |
| 2014-03-31 | $0.01B | $-0.01B | -1.03 |
| 2013-12-31 | $0.01B | $-0.01B | -1.02 |
| 2013-09-30 | $0.01B | $-0.01B | -1.06 |
| 2013-06-30 | $0.01B | $-0.01B | -1.06 |
| 2013-03-31 | $0.01B | $-0.01B | -1.09 |
| 2012-12-31 | $0.01B | $-0.01B | -1.12 |
| 2012-09-30 | $0.00B | $0.00B | 0.00 |
| 2012-06-30 | $0.00B | $0.00B | 0.00 |
| 2012-03-31 | $0.00B | $0.00B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Finance | Finance - SBIC & Commercial | $0.041B | $0.000B |
| Vivos Inc. is a late stage development company. It engaged primarily in the development of brachytherapy devices for therapeutic applications. Vivos Inc., formerly known as Advanced Medical Isotope Corporation, is based in Richland, Washington. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ares Capital (ARCC) | United States | $14.587B | 9.94 |
| Blue Owl Technology Finance (OTF) | United States | $6.430B | 9.15 |
| Blackstone Secured Lending Fund (BXSL) | United States | $6.190B | 8.21 |
| Main Street Capital (MAIN) | United States | $5.298B | 14.82 |
| Golub Capital BDC (GBDC) | United States | $3.735B | 8.55 |
| Hercules Capital (HTGC) | United States | $3.216B | 9.17 |
| Sixth Street Specialty Lending (TSLX) | United States | $2.033B | 9.43 |
| Morgan Stanley Direct Lending Fund (MSDL) | United States | $1.455B | 8.02 |
| Trinity Capital (TRIN) | United States | $1.129B | 7.00 |
| Goldman Sachs BDC (GSBD) | United States | $1.121B | 5.92 |
| Kayne Anderson BDC (KBDC) | United States | $1.004B | 8.58 |
| New Mountain Finance (NMFC) | United States | $0.990B | 7.50 |
| BARINGS BDC, INC (BBDC) | United States | $0.941B | 7.92 |
| Bain Capital Specialty Finance (BCSF) | United States | $0.909B | 7.22 |
| Amalgamated Financial (AMAL) | United States | $0.835B | 7.81 |
| Fidus Investment (FDUS) | United States | $0.719B | 9.18 |
| Nuveen Churchill Direct Lending (NCDL) | United States | $0.718B | 7.34 |
| Carlyle Secured Lending (CGBD) | United States | $0.619B | 7.36 |
| Gladstone Investment (GAIN) | United States | $0.554B | 14.41 |
| CION Investment (CION) | United States | $0.519B | 5.63 |
| BLACKROCK TCP CAPITAL CORP (TCPC) | United States | $0.498B | 4.25 |
| Gladstone Capital (GLAD) | United States | $0.433B | 9.69 |
| PennantPark Investment (PNNT) | United States | $0.428B | 8.40 |
| Palmer Square Capital BDC (PSBD) | United States | $0.382B | 7.03 |
| Runway Growth Finance (RWAY) | United States | $0.361B | 6.16 |
| Saratoga Investment Corp (SAR) | United States | $0.360B | 8.29 |
| Stellus Capital Investment (SCM) | United States | $0.349B | 8.44 |
| Horizon Technology Finance (HRZN) | United States | $0.297B | 5.92 |
| TriplePoint Venture Growth BDC (TPVG) | United States | $0.240B | 5.27 |
| Medallion Financial (MFIN) | United States | $0.232B | 5.40 |
| Chicago Atlantic BDC (LIEN) | United States | $0.229B | 28.69 |
| WhiteHorse Finance (WHF) | United States | $0.161B | 5.93 |
| Oxford Square Capital (OXSQ) | United States | $0.161B | 5.97 |
| PhenixFIN (PFX) | United States | $0.087B | 20.51 |
| Rand Capital (RAND) | United States | $0.041B | 9.13 |
| Investcorp Credit Management BDC (ICMB) | United States | $0.038B | 15.35 |
| OFS Capital (OFS) | United States | $0.000B | 4.97 |
| SLR Investment (SLRC) | United States | $0.000B | 9.38 |
| FS KKR Capital (FSK) | United States | $0.000B | 12.23 |
| Crescent Capital BDC (CCAP) | United States | $0.000B | 7.41 |